Tenaya Therapeutics to Participate in Upcoming Investor Conferences
March 24 2022 - 8:30AM
Business Wire
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology
company with a mission to discover, develop and deliver curative
therapies that address the underlying causes of heart disease,
today announced participation in two upcoming investor
conferences.
Details of each presentation are as follows:
H.C. Wainwright Gene Therapy and Gene Editing Conference
Fireside chat Date: March 30, 2022 Time: 7:00 a.m. ET – available
on demand
Chardan 6th Annual Genetic Medicines Manufacturing Summit
Fireside chat Date: April 26, 2022 Time: 1:00 p.m. ET
Webcasts of the fireside chats will be available by visiting the
Investors section of Tenaya’s website. A replay of each webcast
will be available on the Tenaya website for approximately 30 days
following each conference.
About Tenaya Therapeutics
Tenaya Therapeutics is a biotechnology company committed to a
bold mission: to discover, develop and deliver curative therapies
that address the underlying drivers of heart disease. Founded by
leading cardiovascular scientists from Gladstone Institutes and the
University of Texas Southwestern Medical Center, Tenaya is
developing therapies for rare genetic disorders as well as for more
prevalent heart conditions through three distinct but interrelated
product platforms: Gene Therapy, Cellular Regeneration and
Precision Medicine. For more information, visit
www.tenayatherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220324005528/en/
Investors Michelle Corral Tenaya Therapeutics
IR@tenayathera.com
Media Wendy Ryan Ten Bridge Communications
wendy@tenbridgecommunications.com
Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From Sep 2023 to Sep 2024